Robinhood shares see price target cut to $65 by KBW on earnings miss

Keefe, Bruyette & Woods cut Robinhood’s price target to $65 from $75 while keeping a Market Perform rating, citing an earnings miss of $0.05 per share, adjusted EBITDA of $534 million versus $592 million expected, and weaker revenue trends. The firm also lowered its 2026 EPS estimate by 26% and trimmed 2027-2028 estimates by about 13% each, reflecting softer net interest and transaction revenue assumptions plus higher expenses. While several other analysts remain constructive, the article highlights a more cautious near-term outlook for HOOD.

Analysis

The key read-through is not just idiosyncratic pressure on one growth stock; it is a rerating signal for the broker-as-a-platform model. When estimates come down this sharply on both interest income and trading monetization, it says the market is moving from narrative-driven valuation to a harder cash-flow test, which compresses multiples across the fintech complex if the revenue mix keeps degrading. The highest second-order risk is that Robinhood’s user engagement remains high but monetization per user stalls, forcing a lower terminal multiple even if top-line growth stays positive.

For competitors and peers, the softer print is a relative warning for any name with embedded expectations of a strong rates tailwind or crypto beta. If crypto activity remains weak and net interest income normalizes lower, the market will start valuing these businesses more like mature financial intermediaries than disruptive platforms, which is a bad setup for high-duration equities with 30x+ earnings multiples. That makes the beta-sensitive parts of the fintech basket vulnerable to a mean-reversion trade over the next 1-3 months, especially if broader risk appetite cools.

The contrarian angle is that the estimate reset may already be doing the heavy lifting: a 25-30% forward EPS haircut can be enough to flush out weak holders before the next positive catalyst. If management can stabilize take rates or show a rebound in transactional activity, the stock could re-rate quickly because expectations have been pulled forward less aggressively than the business impairment suggests. The main reversal path is not macro; it is a product-led re-acceleration in engagement and monetization, which would likely show up over the next 1-2 quarters.

Key Decisions for Investors

• Short HOOD on rallies into the next 2-6 weeks; use a tight stop above the post-cut consensus valuation zone. Risk/reward favors downside if the market starts discounting a lower terminal multiple rather than a one-quarter miss.
• Pair trade: long BCS / short HOOD for 1-3 months. Barclays has already reset lower but remains tied to a more diversified earnings base, while HOOD still carries downside from further estimate compression and multiple de-rating.
• Buy HOOD put spreads 1-2 quarters out rather than outright puts. This captures another leg lower if revenue mix weakens again, while limiting theta bleed if the stock chops after the reset.
• Avoid initiating new longs in high-multiple fintech/platform names until the next earnings cycle. The market is likely to punish any company where revenue quality is driven by rate sensitivity or speculative trading volume.
• If HOOD stabilizes above the revised target after the next print, consider a tactical long only on evidence of transaction revenue inflection. The upside case is a fast short-covering rally, but it requires proof that monetization has troughed.